Misdiagnoses of C-choline combined with F-FDG PET imaging in brain tumours

Nuclear Medicine Communications

Volumn 29, Issue 4, 2008, Pages 354-358

  Huang, Zhemin ^a   Zuo, Chuantao ^a   Guan, Yihui ^a   Zhang, Zhengwei ^a   Liu, Ping ^a   Xue, Fangping ^a   Lin, Xiangtong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Brain tumour; Misdiagnosis; Positron emission tomography

Indexed keywords

CHOLINE C 11; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN ABSCESS; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; GRANULOMA; HUMAN; IMAGE ANALYSIS; MALE; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; CHILD; CHOLINE; DIAGNOSTIC ERRORS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 43149096944     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f4a21e     Document Type: Article

References (17)

1. 18F]2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19:1154-1161.
2. 11C]choline. J Nucl Med 1997; 38:842-847.
3. 18F]fluoro-D-glucose in tumor imaging with positron emission tomography. Mol Imaging Biol 2002; 4:267-273.
4. 1H-MRS. J Neurooncol 2003; 62:329-338.
5. Spence AM, Mankoff DA, Muzi M. Positron emission tomography imaging of brain tumors. Neuroimaging Clin N Am 2003; 13:717-739.
6. 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 2003; 99:474-479.
7. Grosu AL, Piert M, Weber WA, Jeremic B, Picchio M, Schratzenstaller U, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005; 181:483-499.
8. Tyler JL, Diksic M, Villemure JG, Evans AC, Meyer E, Yamamoto YL, Feindel W. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 1987; 28:1123-1133.
9. 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation. Ann Nucl Med 2006; 20:527-533.
10. 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging 2004; 31:312-316.
11. 11C-choline PET for the detection of bone and soft tissue tumours in comparison with FDG PET. Nucl Med Commun 2003; 24:273-279.
12. De Stefano N, Filippi M. MR spectroscopy in multiple sclerosis. J Neuroimaging 2007; 17 (Suppl 1):31S-35S.
13. Kwee SA, Coel MN, Lim J, Ko JP. Combined use of F-18 fluorocholine positron emission tomography and magnetic resonance spectroscopy for brain tumor evaluation. J Neuroimaging 2004; 14:285-289.
14. 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 2004; 31:1064-1072.
15. Elstrom R, Guan L, Baker G, Nakhoda K, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood 2003; 101:3875-3876.
16. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2006; 47:2096-2101.
17. Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, Sasaki T. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med 2001; 28:1664-1670.